Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Sana Biotechnology, Inc. (SANA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 187,510,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Sana Biotechnology is a biotechnology company, focusing on utilizing engineered cells as medicines. Co. is developing ex vivo and in vivo cell engineering platforms for treatment across therapeutic areas including oncology, diabetes, central nervous system disorders, cardiovascular diseases, and genetic disorders, among others. Co.'s ex vivo cell engineering pipeline includes its allogeneic T cell program that target CD19 to treat patients with refractory lymphoma. Co.'s in vivo cell engineering pipeline includes its CAR T cell fusosome product candidates (SG242, SG295) target CD19+ cancer cells, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 5,454,543 5,454,543 5,454,543
Total Buy Value $0 $29,999,988 $29,999,988 $29,999,988
Total People Bought 0 3 3 3
Total Buy Transactions 0 3 3 3
Total Shares Sold 25,000 100,000 1,049,000 1,049,000
Total Sell Value $236,300 $536,398 $6,596,531 $6,596,531
Total People Sold 1 2 3 3
Total Sell Transactions 1 2 7 7
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 72
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Afeyan Noubar 10% Owner   –       –       •   2021-02-08 4 A $0.00 $0 I/I 34,239,018 11,585,199     -
   Bishop Hans Edgar Director   –       •      –    2021-02-08 4 A $0.00 $0 D/D 2,031,250 5,736,250     -
   Von Maltzahn Geoffrey Director   –       •      –    2021-02-08 4 A $0.00 $0 I/I 366,122 366,122     -
   Von Maltzahn Geoffrey Director   –       •      –    2021-02-08 4 A $0.00 $0 D/D 1,464,488 1,464,488     -
   Nelsen Robert Director   –       •      –    2021-02-08 4 A $0.00 $0 I/I 43,750,000 11,718,750     -
   Gillis Steven 10% Owner   –       –       •   2021-02-08 4 A $0.00 $0 I/I 43,750,000 11,718,750     -
   Harr Steve President & CEO   •       •      –    2021-02-08 4 A $0.00 $0 D/D 2,031,250 8,173,750     -
   Arch Venture Partners X, Llc 10% Owner   –       –       •   2021-02-08 4 A $0.00 $0 I/I 43,750,000 11,718,750     -
   Bilenker Joshua H.   –       •      –    2021-02-03 4 B $25.00 $500,000 D/D 20,000 20,000 0.01     -
   Gillis Steven 10% Owner   –       –       •   2021-02-03 3 IO $0.00 $0 I/I 0 292,500     -
   Arch Venture Partners X, Llc 10% Owner   –       –       •   2021-02-03 3 IO $0.00 $0 I/I 0 292,500     -
   Hardy Nathan SVP, Chief Financial OfficerOf   •       –      –    2021-02-03 3 IO $0.00 $0 D/D 0 511,250     -
   Agarwal Sunil See RemarksOfficer   •       –      –    2021-02-03 3 IO $0.00 $0 D/D 0 1,610,000     -
   Macdonald James J. See RemarksOfficer   •       –      –    2021-02-03 3 IO $0.00 $0 I/I 0 250,000     -
   Macdonald James J. See RemarksOfficer   •       –      –    2021-02-03 3 IO $0.00 $0 D/D 0 335,000     -
   Yang Patrick Y Director   –       •      –    2021-02-03 3 IO $0.00 $0 D/D 0 146,250     -
   Hordo Christian SVP, Chief Business OfficerOff   •       –      –    2021-02-03 3 IO $0.00 $0 D/D 0 975,000     -
   Mulligan Richard Head of SanaXOfficer   •       •      –    2021-02-03 3 IO $0.00 $0 D/D 0 2,998,121     -
   Bishop Hans Edgar Director   –       •      –    2021-02-03 3 IO $0.00 $0 D/D 0 3,705,000     -
   Harr Steve President & CEOOfficer   •       •      –    2021-02-03 3 IO $0.00 $0 I/I 0 682,500     -
   Harr Steve President & CEOOfficer   •       •      –    2021-02-03 3 IO $0.00 $0 D/D 0 6,142,500     -
   Nelsen Robert Director   –       •      –    2021-02-03 3 IO $0.00 $0 I/I 0 292,500     -

  72 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed